Ligand Pharmaceuticals
LGND
#3449
Rank
NZ$7.02 B
Marketcap
NZ$352.30
Share price
1.04%
Change (1 day)
96.38%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of December 2025 : NZ$1.32 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has NZ$1.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$1.30 B176.68%
2024-12-31NZ$0.47 B75.26%
2023-12-31NZ$0.26 B-19.3%
2022-12-31NZ$0.33 B-33.18%
2021-12-31NZ$0.49 B-12.37%
2020-12-31NZ$0.56 B-64.13%
2019-12-31NZ$1.58 B37.7%
2018-12-31NZ$1.15 B306.28%
2017-12-31NZ$0.28 B39.45%
2016-12-31NZ$0.20 B-30.39%
2015-12-31NZ$0.29 B36.98%
2014-12-31NZ$0.21 B998.34%
2013-12-31NZ$19.44 M29.2%
2012-12-31NZ$15.05 M-31.07%
2011-12-31NZ$21.83 M-25.78%
2010-12-31NZ$29.41 M-59.86%
2009-12-31NZ$73.28 M-47.28%
2008-12-31NZ$0.13 B12.79%
2007-12-31NZ$0.12 B-49.47%
2006-12-31NZ$0.24 B91.79%
2005-12-31NZ$0.12 B-19.33%
2004-12-31NZ$0.15 B3.48%
2003-12-31NZ$0.15 B24.1%
2002-12-31NZ$0.12 B35.26%
2001-12-31NZ$90.75 M69.97%
2000-12-31NZ$53.39 M-40.88%
1999-12-31NZ$90.31 M45.11%
1998-12-31NZ$62.23 M-42.03%
1997-12-31NZ$0.10 B117.96%
1996-12-31NZ$49.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$35.11 B 2,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$23.75 B 1,697.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$12.69 B 860.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.94 B 1,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$3.43 B 159.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$25.44 B 1,825.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$18.64 B 1,311.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$7.43 B 462.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$98.06 M-92.58%๐Ÿ‡บ๐Ÿ‡ธ USA